89,45 €
99,39 €
-10% with code: EXTRA
Pfizer and the Challenges of the Global Pharmaceutical Industry
Pfizer and the Challenges of the Global Pharmaceutical Industry
89,45
99,39 €
  • We will send in 10–14 business days.
This Case Study defines the global pharmaceutical industry and its "boundaries", analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters' Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore it explains and evaluates Pfizer's new strategy and examines what Pfizer did in the recent years to maintain their profitability.
  • SAVE -10% with code: EXTRA

Pfizer and the Challenges of the Global Pharmaceutical Industry (e-book) (used book) | bookbook.eu

Reviews

Description

This Case Study defines the global pharmaceutical industry and its "boundaries", analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters' Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore it explains and evaluates Pfizer's new strategy and examines what Pfizer did in the recent years to maintain their profitability.

EXTRA 10 % discount with code: EXTRA

89,45
99,39 €
We will send in 10–14 business days.

The promotion ends in 20d.02:38:24

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 0,99 Book Euros!?

This Case Study defines the global pharmaceutical industry and its "boundaries", analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters' Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore it explains and evaluates Pfizer's new strategy and examines what Pfizer did in the recent years to maintain their profitability.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)